Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Vaccination Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Egg Based
1.2.3 Cell Culture
1.2.4 Recombinant
1.3 Market by Application
1.3.1 Global Influenza Vaccination Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Research Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Vaccination Market Perspective (2024-2034)
2.2 Influenza Vaccination Growth Trends by Region
2.2.1 Global Influenza Vaccination Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Influenza Vaccination Historic Market Size by Region (2024-2024)
2.2.3 Influenza Vaccination Forecasted Market Size by Region (2024-2034)
2.3 Influenza Vaccination Market Dynamics
2.3.1 Influenza Vaccination Industry Trends
2.3.2 Influenza Vaccination Market Drivers
2.3.3 Influenza Vaccination Market Challenges
2.3.4 Influenza Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Vaccination Players by Revenue
3.1.1 Global Top Influenza Vaccination Players by Revenue (2024-2024)
3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2024-2024)
3.2 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza Vaccination Revenue
3.4 Global Influenza Vaccination Market Concentration Ratio
3.4.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2022
3.5 Influenza Vaccination Key Players Head office and Area Served
3.6 Key Players Influenza Vaccination Product Solution and Service
3.7 Date of Enter into Influenza Vaccination Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Vaccination Breakdown Data by Type
4.1 Global Influenza Vaccination Historic Market Size by Type (2024-2024)
4.2 Global Influenza Vaccination Forecasted Market Size by Type (2024-2034)
5 Influenza Vaccination Breakdown Data by Application
5.1 Global Influenza Vaccination Historic Market Size by Application (2024-2024)
5.2 Global Influenza Vaccination Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Influenza Vaccination Market Size (2024-2034)
6.2 North America Influenza Vaccination Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Influenza Vaccination Market Size by Country (2024-2024)
6.4 North America Influenza Vaccination Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Influenza Vaccination Market Size (2024-2034)
7.2 Europe Influenza Vaccination Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Influenza Vaccination Market Size by Country (2024-2024)
7.4 Europe Influenza Vaccination Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Vaccination Market Size (2024-2034)
8.2 Asia-Pacific Influenza Vaccination Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Influenza Vaccination Market Size by Region (2024-2024)
8.4 Asia-Pacific Influenza Vaccination Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Influenza Vaccination Market Size (2024-2034)
9.2 Latin America Influenza Vaccination Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Influenza Vaccination Market Size by Country (2024-2024)
9.4 Latin America Influenza Vaccination Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Vaccination Market Size (2024-2034)
10.2 Middle East & Africa Influenza Vaccination Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Influenza Vaccination Market Size by Country (2024-2024)
10.4 Middle East & Africa Influenza Vaccination Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott (U.S.)
11.1.1 Abbott (U.S.) Company Detail
11.1.2 Abbott (U.S.) Business Overview
11.1.3 Abbott (U.S.) Influenza Vaccination Introduction
11.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2024-2024)
11.1.5 Abbott (U.S.) Recent Development
11.2 AstraZeneca (Europe)
11.2.1 AstraZeneca (Europe) Company Detail
11.2.2 AstraZeneca (Europe) Business Overview
11.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
11.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2024-2024)
11.2.5 AstraZeneca (Europe) Recent Development
11.3 BioCryst Pharmaceuticals (U.S.)
11.3.1 BioCryst Pharmaceuticals (U.S.) Company Detail
11.3.2 BioCryst Pharmaceuticals (U.S.) Business Overview
11.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Introduction
11.3.4 BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2024-2024)
11.3.5 BioCryst Pharmaceuticals (U.S.) Recent Development
11.4 Novartis (Europe)
11.4.1 Novartis (Europe) Company Detail
11.4.2 Novartis (Europe) Business Overview
11.4.3 Novartis (Europe) Influenza Vaccination Introduction
11.4.4 Novartis (Europe) Revenue in Influenza Vaccination Business (2024-2024)
11.4.5 Novartis (Europe) Recent Development
11.5 DAIICHI SANKYO COMPANY (Asia Pacific)
11.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Company Detail
11.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
11.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Introduction
11.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2024-2024)
11.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
11.6 GlaxoSmithKline (Europe)
11.6.1 GlaxoSmithKline (Europe) Company Detail
11.6.2 GlaxoSmithKline (Europe) Business Overview
11.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Introduction
11.6.4 GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2024-2024)
11.6.5 GlaxoSmithKline (Europe) Recent Development
11.7 Hualan Biological Engineering (Asia Pacific)
11.7.1 Hualan Biological Engineering (Asia Pacific) Company Detail
11.7.2 Hualan Biological Engineering (Asia Pacific) Business Overview
11.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Introduction
11.7.4 Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2024-2024)
11.7.5 Hualan Biological Engineering (Asia Pacific) Recent Development
11.8 Mitsubishi Tanabe Pharma (Asia Pacific)
11.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Company Detail
11.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
11.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Introduction
11.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2024-2024)
11.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
11.9 F. Hoffmann-La Roche (Europe)
11.9.1 F. Hoffmann-La Roche (Europe) Company Detail
11.9.2 F. Hoffmann-La Roche (Europe) Business Overview
11.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Introduction
11.9.4 F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2024-2024)
11.9.5 F. Hoffmann-La Roche (Europe) Recent Development
11.10 Sanofi (Europe)
11.10.1 Sanofi (Europe) Company Detail
11.10.2 Sanofi (Europe) Business Overview
11.10.3 Sanofi (Europe) Influenza Vaccination Introduction
11.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2024-2024)
11.10.5 Sanofi (Europe) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Influenza Vaccination Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Egg Based
Table 3. Key Players of Cell Culture
Table 4. Key Players of Recombinant
Table 5. Global Influenza Vaccination Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Influenza Vaccination Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Influenza Vaccination Market Size by Region (2024-2024) & (US$ Million)
Table 8. Global Influenza Vaccination Market Share by Region (2024-2024)
Table 9. Global Influenza Vaccination Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Influenza Vaccination Market Share by Region (2024-2034)
Table 11. Influenza Vaccination Market Trends
Table 12. Influenza Vaccination Market Drivers
Table 13. Influenza Vaccination Market Challenges
Table 14. Influenza Vaccination Market Restraints
Table 15. Global Influenza Vaccination Revenue by Players (2024-2024) & (US$ Million)
Table 16. Global Influenza Vaccination Market Share by Players (2024-2024)
Table 17. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2022)
Table 18. Ranking of Global Top Influenza Vaccination Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Influenza Vaccination Revenue (CR5 and HHI) & (2024-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Influenza Vaccination Product Solution and Service
Table 22. Date of Enter into Influenza Vaccination Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Influenza Vaccination Market Size by Type (2024-2024) & (US$ Million)
Table 25. Global Influenza Vaccination Revenue Market Share by Type (2024-2024)
Table 26. Global Influenza Vaccination Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Influenza Vaccination Revenue Market Share by Type (2024-2034)
Table 28. Global Influenza Vaccination Market Size by Application (2024-2024) & (US$ Million)
Table 29. Global Influenza Vaccination Revenue Market Share by Application (2024-2024)
Table 30. Global Influenza Vaccination Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Influenza Vaccination Revenue Market Share by Application (2024-2034)
Table 32. North America Influenza Vaccination Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 33. North America Influenza Vaccination Market Size by Country (2024-2024) & (US$ Million)
Table 34. North America Influenza Vaccination Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Influenza Vaccination Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. Europe Influenza Vaccination Market Size by Country (2024-2024) & (US$ Million)
Table 37. Europe Influenza Vaccination Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Influenza Vaccination Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Asia-Pacific Influenza Vaccination Market Size by Region (2024-2024) & (US$ Million)
Table 40. Asia-Pacific Influenza Vaccination Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Influenza Vaccination Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 42. Latin America Influenza Vaccination Market Size by Country (2024-2024) & (US$ Million)
Table 43. Latin America Influenza Vaccination Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Influenza Vaccination Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 45. Middle East & Africa Influenza Vaccination Market Size by Country (2024-2024) & (US$ Million)
Table 46. Middle East & Africa Influenza Vaccination Market Size by Country (2024-2034) & (US$ Million)
Table 47. Abbott (U.S.) Company Detail
Table 48. Abbott (U.S.) Business Overview
Table 49. Abbott (U.S.) Influenza Vaccination Product
Table 50. Abbott (U.S.) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 51. Abbott (U.S.) Recent Development
Table 52. AstraZeneca (Europe) Company Detail
Table 53. AstraZeneca (Europe) Business Overview
Table 54. AstraZeneca (Europe) Influenza Vaccination Product
Table 55. AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 56. AstraZeneca (Europe) Recent Development
Table 57. BioCryst Pharmaceuticals (U.S.) Company Detail
Table 58. BioCryst Pharmaceuticals (U.S.) Business Overview
Table 59. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product
Table 60. BioCryst Pharmaceuticals (U.S.) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 61. BioCryst Pharmaceuticals (U.S.) Recent Development
Table 62. Novartis (Europe) Company Detail
Table 63. Novartis (Europe) Business Overview
Table 64. Novartis (Europe) Influenza Vaccination Product
Table 65. Novartis (Europe) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 66. Novartis (Europe) Recent Development
Table 67. DAIICHI SANKYO COMPANY (Asia Pacific) Company Detail
Table 68. DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
Table 69. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product
Table 70. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 71. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Development
Table 72. GlaxoSmithKline (Europe) Company Detail
Table 73. GlaxoSmithKline (Europe) Business Overview
Table 74. GlaxoSmithKline (Europe) Influenza Vaccination Product
Table 75. GlaxoSmithKline (Europe) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 76. GlaxoSmithKline (Europe) Recent Development
Table 77. Hualan Biological Engineering (Asia Pacific) Company Detail
Table 78. Hualan Biological Engineering (Asia Pacific) Business Overview
Table 79. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product
Table 80. Hualan Biological Engineering (Asia Pacific) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 81. Hualan Biological Engineering (Asia Pacific) Recent Development
Table 82. Mitsubishi Tanabe Pharma (Asia Pacific) Company Detail
Table 83. Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
Table 84. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product
Table 85. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 86. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Development
Table 87. F. Hoffmann-La Roche (Europe) Company Detail
Table 88. F. Hoffmann-La Roche (Europe) Business Overview
Table 89. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product
Table 90. F. Hoffmann-La Roche (Europe) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 91. F. Hoffmann-La Roche (Europe) Recent Development
Table 92. Sanofi (Europe) Company Detail
Table 93. Sanofi (Europe) Business Overview
Table 94. Sanofi (Europe) Influenza Vaccination Product
Table 95. Sanofi (Europe) Revenue in Influenza Vaccination Business (2024-2024) & (US$ Million)
Table 96. Sanofi (Europe) Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Vaccination Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Influenza Vaccination Market Share by Type: 2022 VS 2034
Figure 3. Egg Based Features
Figure 4. Cell Culture Features
Figure 5. Recombinant Features
Figure 6. Global Influenza Vaccination Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Influenza Vaccination Market Share by Application: 2022 VS 2034
Figure 8. Hospitals Case Studies
Figure 9. Research Organizations Case Studies
Figure 10. Influenza Vaccination Report Years Considered
Figure 11. Global Influenza Vaccination Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 12. Global Influenza Vaccination Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Influenza Vaccination Market Share by Region: 2022 VS 2034
Figure 14. Global Influenza Vaccination Market Share by Players in 2022
Figure 15. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Influenza Vaccination Revenue in 2022
Figure 17. North America Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 18. North America Influenza Vaccination Market Share by Country (2024-2034)
Figure 19. United States Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. Canada Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Europe Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Europe Influenza Vaccination Market Share by Country (2024-2034)
Figure 23. Germany Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. France Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. U.K. Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Italy Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Russia Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Nordic Countries Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Asia-Pacific Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Asia-Pacific Influenza Vaccination Market Share by Region (2024-2034)
Figure 31. China Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Japan Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. South Korea Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Southeast Asia Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. India Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Australia Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Latin America Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Latin America Influenza Vaccination Market Share by Country (2024-2034)
Figure 39. Mexico Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Brazil Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Middle East & Africa Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Middle East & Africa Influenza Vaccination Market Share by Country (2024-2034)
Figure 43. Turkey Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Saudi Arabia Influenza Vaccination Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Abbott (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 46. AstraZeneca (Europe) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 47. BioCryst Pharmaceuticals (U.S.) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 48. Novartis (Europe) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 49. DAIICHI SANKYO COMPANY (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 50. GlaxoSmithKline (Europe) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 51. Hualan Biological Engineering (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 52. Mitsubishi Tanabe Pharma (Asia Pacific) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 53. F. Hoffmann-La Roche (Europe) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 54. Sanofi (Europe) Revenue Growth Rate in Influenza Vaccination Business (2024-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed